Alcohol companies like Heineken, Constellation Brands, and AB InBev have been preparing for a customer culture shift toward ...

Anheuser-Busch Inbev SA (BUD) stock saw a decline, ending the day at $48.85 which represents a decrease of $-1.08 or -2.16% from the prior close of $49.93. The stock opened at $49.4 and touched a low ...

The Anheuser-Busch InBev S.A. ADR shed 0.28% to $49.93 Thursday, on what proved to be an all-around rough trading session for ...

BUD stock continues its downtrend due to ongoing cost headwinds. However, its focus on premiumization and the Beyond Beer ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

The US Surgeon General's advisory on cancer and alcohol sent shares of beverage makers lower, but its effects may be much ...

Companies like Molson Coors, Anheuser-Busch InBev, and Diageo are investing heavily in zero-proof alternatives, with products ...

Russian President Vladimir Putin has given a local company control of Anheuser-Busch InBev’s joint venture, upending the ...

Central Pacific Bank Trust Division raised its position in shares of Anheuser-Busch InBev SA/NV (NYSE:BUD – Free Report) by ...

Popular alcohol producers had a bumpy morning as investors reacted to an advisory from the U.S. Surgeon General about alcohol and cancer.

Shares in beer, wine and spirits companies such as Anheuser-Busch InBev, Boston Beer and Constellation Brands fell after the ...